Assessing theoretical risk and benefit suggested by genetic association studies of CCR5: experience in a drug development programme for maraviroc. (Q36822253)
Jump to navigation
Jump to search
scientific article published on January 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Assessing theoretical risk and benefit suggested by genetic association studies of CCR5: experience in a drug development programme for maraviroc. |
scientific article published on January 2007 |
Statements
Assessing theoretical risk and benefit suggested by genetic association studies of CCR5: experience in a drug development programme for maraviroc (English)
Jeremy Wheeler
Mary McHale
Vicky Jackson